SUCAMPO PHARMACEUTICALS, INC. Inactive Instrument
Company Sucampo Pharmaceuticals, Inc.
Equities
US8649091068
Biotechnology & Medical Research
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 46,636,924 | 45,389,949 ( 97.33 %) | 227,266 ( 0.4873 %) | 97.33 % |
Company contact information
Sucampo Pharmaceuticals, Inc.
805 King Farm Boulevard Suite 550
20850, Rockville
+301-961-3400
http://sucampo.com
Group companies
| Name | Category and Sector |
|---|---|
Sucampo Pharma LLC
 Sucampo Pharma LLC Miscellaneous Commercial ServicesCommercial Services Sucampo Pharma LLC engages in the pharmaceutical product development. It develops the naturally occurring compound prostones, including lubiprostone under the brand Amitiza, which is used for the treatment of chronic constipation, chronic idiopathic constipation (CIC) in adults, and irritable bowel syndrome with constipation (IBS-C). The company is headquartered in Osaka, Japan. |
Miscellaneous Commercial Services
|
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +2.49% | 96.73B | |
| -0.32% | 21.31B | |
| -16.61% | 21.21B | |
| -5.15% | 18.79B | |
| -42.14% | 16.37B | |
| -27.40% | 13.68B | |
| +1.44% | 13.44B | |
| +21.29% | 10.98B | |
| -21.79% | 8.56B |
